Icariin Modulates the Reproductive-Immune Axis: Molecular Insights and Therapeutic Potential
Current Issues in Molecular Biology · 01.04.2026 · 48 (4) · 366
DOI: 10.3390/cimb48040366 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 01.04.2026. Verfasst von Rongyu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural science foundation project of Sichuan, the Key Research and Development Program of Chengdu, the Young Teachers' Science and Technology Innovation Capability Enhancement Project of Sichuan University.
Abstract (Originalsprache)
The immune system is a pivotal regulator of reproductive physiology, maintaining tissue homeostasis essential for successful pregnancy while contributing to infertility and reproductive disorders when dysregulated. Natural products represent a valuable source of novel immunomodulatory agents. Icariin (ICA), a prenylated flavonoid glycoside isolated from Epimedium species (Horny Goat Weed), has a long-standing traditional use for “invigorating yang,” which modern research attributes to its reproductive function-enhancing properties. This review synthesizes emerging evidence that the beneficial effects of ICA on female and male reproductive health are primarily mediated through its sophisticated immunomodulatory actions on the reproductive–immune axis. We systematically dissect the molecular mechanisms by which ICA reprograms the reproductive immune microenvironment, focusing on its regulation of macrophage polarization, T-helper cell (Th1/Th2/Th17) and regulatory T-cell (Treg) balance, and suppression of key pro-inflammatory signaling pathways (NF-κB, NLRP3 inflammasome, JAK-STAT) in ovarian, uterine, and testicular tissues. This review provides a detailed account of how ICA modulates reproductive disorders via regulating immune responses, with the aim of offering innovative strategies for the design of novel immunomodulatory therapies targeting reproductive diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University Ministry of Education, Chengdu 610041, China.
- Reproductive Endocrinology and Regulation Laboratory, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
- Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
- National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Förderung
- Natural science foundation project of Sichuan
- the Key Research and Development Program of Chengdu
- the Young Teachers' Science and Technology Innovation Capability Enhancement Project of Sichuan University
- Key Research and Development Program of Chengdu
- Young Teachers’ Science and Technology Innovation Capability Enhancement Project of Sichuan University
- National Natural Science Foundation of China
Zitieren
APA
Wang, R., Chen, Y., Xiao, Q., Tang, L., & Zhang, N. (2026). Icariin Modulates the Reproductive-Immune Axis: Molecular Insights and Therapeutic Potential. Current Issues in Molecular Biology, 48(4), 366. https://doi.org/10.3390/cimb48040366
Vancouver
Wang R, Chen Y, Xiao Q, Tang L, Zhang N. Icariin Modulates the Reproductive-Immune Axis: Molecular Insights and Therapeutic Potential. Current Issues in Molecular Biology. 2026;48(4):366. doi:10.3390/cimb48040366
BibTeX
@article{Wang2026,
author = {Wang, Rongyu and Chen, Yan and Xiao, Qinwen and Tang, Lirong and Zhang, Nannan},
title = {Icariin Modulates the Reproductive-Immune Axis: Molecular Insights and Therapeutic Potential},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {4},
pages = {366},
doi = {10.3390/cimb48040366}
}
EUVIMED